Novel DNA capable of being amplified by PCR with high selectivity and high efficiency

Details for Australian Patent Application No. 2009232716 (hide)

Owner TagCyx Biotechnologies

Inventors Yokoyama, Shigeyuki; Hirao, Ichiro; Hirao, Michiko

Agent Griffith Hack

Pub. Number AU-A-2009232716

PCT Pub. Number WO2009/123216

Priority 2008-094255 31.03.08 JP

Filing date 31 March 2009

Wipo publication date 8 October 2009

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 31/7115 (2006.01) - Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

25 November 2010 Assignment before Grant

  TagCyx Biotechnologies; RIKEN The application has been assigned to TagCyx Biotechnologies

25 November 2010 PCT application entered the National Phase

  PCT publication WO2009/123216 Priority application(s): WO2009/123216

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009232721-Pyrimidine derivative having cellprotecting activity and use thereof

2009232715-Preparation for preventing or ameliorating wrinkles, to be taken orally, through injection, or through external application to skin, and cosmetic method